LSPW
CBAY

Lake Street Private Wealth’s Cymabay Therapeutics CBAY Stock Holding History

Lake Street Private Wealth’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,900
Closed -$112K – 303
2023
Q1 		$112K Hold
12,900
– – 0.02% 272
2022
Q4 		$80.9K Hold
12,900
– – 0.02% 270
2022
Q3 		$45K Hold
12,900
– – 0.01% 270
2022
Q2 		$38K Hold
12,900
– – 0.01% 287
2022
Q1 		$40K Hold
12,900
– – 0.01% 305
2021
Q4 		$44K Hold
12,900
– – 0.01% 323
2021
Q3 		$47K Buy
+12,900
New +$50.8K 0.01% 231

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return